Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Translational Oncology|October 3, 2020
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Laura L Stafman, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastomaColin H Quinn, Janet R Julson, Hooper R Markert, et al.
International Journal of Molecular Sciences|May 14, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of <i>TRIM29</i>Swatika Butey, Morgan L Brown, Janet R Julson, et al.
Journal of Pediatric Surgery|March 25, 2021
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Colin H Quinn, et al.
ACS Omega|September 19, 2022
Rapid Characterization of Solid Tumors Using Resonant SensorsAndee M Beierle, Colin H Quinn, Hooper R Markert, et al.
Cancer Gene Therapy|April 17, 2021
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cellsRaoud Marayati, Laura L Stafman, Adele P Williams, et al.
Scientific Reports|March 17, 2021
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastomaRaoud Marayati, Laura L Stafman, Adele P Williams, et al.
Plos One|March 10, 2021
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growthLaura V Bownes, Adele P Williams, Raoud Marayati, et al.
Pageof 4